Target intelligence / Profile preview

TBC1 domain family member 16 (TBC1D16)

Target
TBC1D16
Molecular classification
Rab GTPase-activating protein (GAP), Enzyme, Intracellular trafficking/trafficking regulator, Other (TBC domain-containing protein)
01

Overview

TBC1 domain family member 16 (TBC1D16) is a cytosolic enzyme classified as a Rab GTPase-activating protein, characterized by a conserved TBC (Tre2/Bub2/Cdc16) domain and serine-rich C-terminal region. TBC1D16 regulates intracellular trafficking by acting as a negative regulator of specific Rab GTPases (notably Rab4A and Rab5C), modulating receptor recycling and degradation for proteins such as EGFR and the transferrin receptor. TBC1D16 functions as a host restriction factor against certain viruses (e.g., prototype foamy virus), inhibiting viral replication, and promoting type I interferon responses. In cancer, particularly melanoma, aberrant activation of TBC1D16 (e.g., the 47 kDa isoform) contributes to tumor growth and metastasis by disrupting trafficking and signaling pathways pivotal to cell proliferation and survival.

Other names
TBC1D16MGC25062FLJ20748CTD-2529O21.1
02

Mechanism of action

Acts as a GTPase-activating protein (GAP) for Rab GTPases, especially Rab4A and Rab5C, thereby modulating trafficking and signaling of receptors (such as EGFR); Inhibits viral gene transcription and replication by interacting with Rab5C; Promotes type I interferon responses during viral infection

03

Biological functions

Regulation of receptor recycling (such as EGFR and transferrin receptor)Intracellular protein traffickingRegulation of GTPase activityInhibition of viral replication (notably PFV replication)Regulation of type I IFN production and downstream gene transcription
04

Disease associations

Cancer (notably melanoma, where aberrant TBC1D16 activity drives tumor growth and metastasis)Infection (restricts prototype foamy virus—PFV—replication)
05

Safety considerations

Aberrant upregulation or epigenetic reactivation in cancers such as melanoma may enhance tumorigenesis and metastasis
06

Biomarkers

Short isoform TBC1D16-47KD may serve as a biomarker in melanoma for aggressive disease and poor prognosis

Beyond the preview

Go deeper on TBC1 domain family member 16 (TBC1D16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 16 (TBC1D16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call